TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review August 14, 1992
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991